Company intelligence / Profile preview

Dosentrx

Ownership: Private
Development stage: Other

Overview

Clinical studies show that the ReX platform significantly improves patient adherence to prescribed regimens compared to standard of care. Reported results include 97.4% of patients sticking to their treatment plan, 100% safety in use, 94.4% continuing required medication duration, and high user satisfaction rates.

Therapeutic areas: Other
Modalities: DeviceDigital therapy program
Industry: Digital Health Medical Devices

Partnerships

Contents Trader (Houston, TX) – joint development of homecare medication tracking technology via BIRD Foundation grant

Beyond the preview

Go deeper on Dosentrx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dosentrx.

Explore the full profile